Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT04109820

Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia

Led by University of Pittsburgh · Updated on 2025-06-19

15

Participants Needed

5

Research Sites

382 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

MitoQ is commercially available as a dietary supplement and it has been tested as a potential drug in other diseases, but it has never been tested in patients with sickle cell disease. The goal of this research is to study if MitoQ, a molecule that works as an antioxidant by removing potentially damaging agents in a living organism, improves platelet function in patients with sickle cell disease (SCD).

CONDITIONS

Official Title

Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be African American
  • Have sickle cell anemia (for subjects)
  • Be a healthy African American volunteer (for control group)
  • Be 18 years old or older
Not Eligible

You will not qualify if you...

  • Currently pregnant
  • Have known hypertension
  • Are undergoing hemodialysis
  • Have active obstructive sleep apnea requiring treatment
  • Use anti-platelet medication or have had a blood transfusion within 4 weeks prior to enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Magee Women's Hospital

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

2

UPMC Montefiore

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

3

UPMC Presbyterian

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

4

Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15224

Actively Recruiting

5

Hillman Cancer Center

Pittsburgh, Pennsylvania, United States, 15232

Actively Recruiting

Loading map...

Research Team

M

Mikhil N Bamne, PhD

CONTACT

J

Jude Jonassaint, RN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here